| abstract |
The invention relates to heterocyclic aminoalkyl pyridine derivatives of the formula (I) (see formula) where R 1 is the radical of a heterocycle with 1 to 3 ring structures, where each ring structure is saturated, unsaturated or aromatic, and optionally it is fused with other ring structures to give a condensed ring system, the heterocycle having a total of 1 to 4 atoms of N, O and / or S in the ring structures, and optionally this mono-, bi- or trisubstituted by one or more of the groups -A, -OR4, -N (R4) 2, -NO2, -CN, Hal, -COOR4, -CON (R4) 2, -COR4, = 0; R2 means a phenyl group, optionally mono-, bi-, tri-, tetra- or pentas substituted by one or more of the groups Hal, A, -OA, -NO2 or -CN, or means a thienyl group, optionally mono- or bis substituted with one or more of the groups Hal, A, -OA, -NO2, -CN or thienyl; Xes -O-, -S-, sulfinyl, sulfonyl, - C (R4) 2 -; Y is - [C (R4) 2 (n-; Z is -C (R4) 2 -; n is 1,2,3 or 4; as well as its compatible salts and solvates and its use as a medicine. |